Cargando…
Mechanisms of Tumor Development and Anti-angiogenic Therapy in Glioblastoma Multiforme
Despite advances in surgical and medical therapy, glioblastoma multiforme (GBM) remains a fatal disease. There has been no significant increase in survival for patients with this disease over the last 20 years. Tumor vasculature formation and glioma cell invasion along the white matter tracts both p...
Autores principales: | Onishi, Manabu, Kurozumi, Kazuhiko, Ichikawa, Tomotsugu, Date, Isao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japan Neurosurgical Society
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4508716/ https://www.ncbi.nlm.nih.gov/pubmed/24162241 http://dx.doi.org/10.2176/nmc.ra2013-0200 |
Ejemplares similares
-
New Treatment Strategies to Eradicate Cancer Stem Cells and Niches in Glioblastoma
por: Hide, Takuichiro, et al.
Publicado: (2013) -
Treatment Results of Glioblastoma during the Last 30 Years in a Single Institute
por: Kumabe, Toshihiro, et al.
Publicado: (2013) -
Retrospective Analysis of Bevacizumab in Combination with Ifosfamide, Carboplatin, and Etoposide in Patients with Second Recurrence of Glioblastoma
por: Arakawa, Yoshiki, et al.
Publicado: (2013) -
Advantages of Dose-Dense Methotrexate Protocol for Primary Central Nervous System Lymphoma: Comparison of Two Different Protocols at a Single Institution
por: Aoki, Hiroshi, et al.
Publicado: (2013) -
Dendritic Cell-Based Immunotherapy for Glioma: Multiple Regimens and Implications in Clinical Trials
por: Mineharu, Yohei, et al.
Publicado: (2013)